James F. Humphreys & Associates
Practice Area Quick Menu
Practice Area Quick Menu
Have you or a loved one been a victim of ...
We are a Top Legal firm that can provide you all the services and resources to win your case.
The drug Arcoxia has been described as the next-generation version of Vioxx, Merck's blockbuster arthritis medication that was recalled in September 2004 after it was determined to increase patients' risk of heart attack and stroke. Vioxx and Arcoxia are both COX-2 inhibitors used in the treatment of arthritis pain. Merck is already selling Arcoxia in Europe, Latin America and Asia and the FDA is expected to rule on Arcoxia's entrance to the U.S. market soon. Although recent scientific data indicates Arcoxia does not have the same adverse effects as Vioxx, a study noted the drug did raise blood pressure in some patients. This study looked at patients taking the drug for just a year, which based on the Vioxx recall, may not be enough time to show the potential side effects. Longer- term studies for Arcoxia will not be available until 2006.
The attorneys of James F. Humphreys & Associates have extensive experience in Vioxx litigation and therefore have a thorough understanding of all COX-2 inhibitors and the adverse effects this class of drugs often has on patients. Our firm understands the risks Arcoxia poses and that those risks are similar to Vioxx's, a drug taken off the market for its ability to injure and in some instances, cause death to consumers.
If you think you may be suffering from side effects caused by Vioxx, contact an attorney of James F. Humphreys & Associates. Fill out a free case evaluator now.